Correction: Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigation

RSC Adv. 2023 Apr 6;13(16):10956. doi: 10.1039/d3ra90030d. eCollection 2023 Apr 3.

Abstract

[This corrects the article DOI: 10.1039/D3RA00526G.].

Publication types

  • Published Erratum